Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Cencora Inc., 3 years.
Cencora Inc.
Director
Revolution Medicines Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cencora Inc. March 5, 202698.9%
-
Cencora Inc. March 6, 202598.7%
-
Revolution Medicines Inc. June 20, 202474.6%
-
Cencora Inc. March 12, 202499.1%
-
Cencora Inc. March 9, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Revolution Medicines Inc. | Open-market sale | −706 | $206.60 | $145,863 |
| Sep 8, 2026 | Revolution Medicines Inc. | Open-market sale | −999 | $207.33 | $207,125 |
| Sep 8, 2026 | Revolution Medicines Inc. | Open-market sale | −3,587 | $208.55 | $748,081 |
| Sep 8, 2026 | Revolution Medicines Inc. | Open-market sale | −2,853 | $209.56 | $597,875 |
| Sep 8, 2026 | Revolution Medicines Inc. | Open-market sale | −4,730 | $210.50 | $995,678 |
| Sep 8, 2026 | Revolution Medicines Inc. | Open-market sale | −3,844 | $211.36 | $812,463 |
| Sep 8, 2026 | Revolution Medicines Inc. | Open-market sale | −371 | $212.27 | $78,752 |
| Aug 31, 2026 | Revolution Medicines Inc. | Open-market sale | −300 | $200.56 | $60,168 |
| Aug 31, 2026 | Revolution Medicines Inc. | Open-market sale | −6,597 | $201.47 | $1,329,117 |
| Aug 31, 2026 | Revolution Medicines Inc. | Open-market sale | −12,919 | $202.48 | $2,615,864 |
| Aug 31, 2026 | Revolution Medicines Inc. | Open-market sale | −26,160 | $203.55 | $5,324,824 |
| Aug 31, 2026 | Revolution Medicines Inc. | Open-market sale | −7,271 | $204.35 | $1,485,830 |
| Aug 31, 2026 | Revolution Medicines Inc. | Open-market sale | −2,128 | $205.19 | $436,640 |
| Aug 31, 2026 | Revolution Medicines Inc. | Open-market sale | −625 | $206.15 | $128,846 |
| Jun 18, 2026 | Revolution Medicines Inc. | Grant or award | +1,191 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.